Bilastine
- Generic Name
- Bilastine
- Brand Names
- Blexten
- Drug Type
- Small Molecule
- Chemical Formula
- C28H37N3O3
- CAS Number
- 202189-78-4
- Unique Ingredient Identifier
- PA1123N395
Overview
Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Background
Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Indication
For symptomatic relief of nasal and non-nasal symptoms of seasonal rhinitis in patients 12 years of age and older and for symptomatic relief in chronic spontaneous urticaria in patients 18 years of age and older .
Associated Conditions
- Chronic Spontaneous Urticaria
- Seasonal Allergic Rhinitis
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
ALIGRIN TABLET 20MG
Manufacturer:A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.R.L.
Form:TABLET
Strength:20MG
Online:Yes
Approved: 2022/04/12
Approval:SIN16474P
BILAXTEN TABLET 20 mg
Manufacturer:A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.
Form:TABLET
Strength:20.00 mg
Online:Yes
Approved: 2014/11/11
Approval:SIN14661P
BILAXTEN ORODISPERSIBLE TABLET 10MG
Manufacturer:A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.
Form:TABLET, ORALLY DISINTEGRATING
Strength:10MG/TABLET
Online:Yes
Approved: 2020/01/13
Approval:SIN15874P
BILAXTEN ORAL SOLUTION 2.5MG/ML
Manufacturer:BERLIN-CHEMIE AG
Form:SOLUTION
Strength:2.5MG/ML
Online:Yes
Approved: 2020/06/24
Approval:SIN15963P
BILAXTEN TABLET 20 MG (PHARMACY ONLY)
Manufacturer:A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.
Form:TABLET
Strength:20.00 mg
Online:Yes
Approved: 2024/10/02
Approval:SIN17104P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath